Godlike Productions - Discussion Forum
Users Online Now: 1,966 (Who's On?)Visitors Today: 586,501
Pageviews Today: 1,282,586Threads Today: 473Posts Today: 10,573
06:08 PM


Rate this Thread

Absolute BS Crap Reasonable Nice Amazing
 

FDA Approves Experimental H1N1 Swine Flu Vaccine Prior to Children Safety Trials Beginning

 
LeoJuly24
Offer Upgrade

User ID: 763463
United States
09/18/2009 09:22 PM
Report Abusive Post
Report Copyright Violation
FDA Approves Experimental H1N1 Swine Flu Vaccine Prior to Children Safety Trials Beginning
[link to lib.store.yahoo.net]

FDA Approves Experimental H1N1 Swine Flu Vaccine Prior to Children Safety Trials Beginning
Jeffry John Aufderheide

VacTRUTH.COM
09/16/09

In a stunning move, the FDA has approved four monovalent Swine Flu vaccines for the following companies: CSL Limited, MedImmune LLC, Novartis Vaccines and Diagnostics Limited, and Sanofi Pasteur, Inc. Adding to the confusion is the fact that purported ’safety trials’ for the Swine Flu vaccine haven’t even begun, in some instances.

By example, Novartis is just starting vaccine safety trials for three to eight year old children supposedly as of 09/15/09 as reported in the last article I wrote entitled, “Ingredients Found in Spermicides, Cleaners, and Cosmetics along with Thimerosal, and Squalene Present in Experimental H1N1 Vaccine“. One can only wonder as to what head FDA officials are thinking when they approved the vaccine on the same day. Yet, according to the newly released package inserts, we now know exactly why this decision was made.

The document concerning the Novartis trial becomes a pivotal piece in discerning what is happening behind closed doors. Generally speaking, all four package inserts communicate the same message and are structured similarly. Therefore, we will select quotes from the Novartis insert for the purposes of this article.

—-For the reader’s edification, here are links to information concerning the vaccine by manufacturer—-

•(Injectable)Influenza A (H1N1) 2009 Monovalent Vaccine (CSL Limited)
•(Injectable)Influenza A (H1N1) 2009 Monovalent Vaccine (Novartis Vaccines and Diagnostics Limited)
•(Injectable)Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur, Inc.)
•(Intranasal)Influenza A (H1N1) 2009 Monovalent Vaccine (MedImmune LLC)
PAST STUDIES ARE THE JUSTIFICATION FOR APPROVAL


How does a vaccine get approved without being properly tested for safety? The press release entitled “FDA Approves Vaccines for 2009 H1N1 Influenza Virus” which can be read here gives us our first clue…

“Based on preliminary data from adults participating in multiple clinical studies, the 2009 H1N1 vaccines induce a robust immune response in most healthy adults eight to 10 days after a single dose, as occurs with the seasonal influenza vaccine.”


“Clinical studies under way will provide additional information about the optimal dose in children. The recommendations for dosing will be updated if indicated by findings from those studies. The findings are expected in the near future.”

Needless to say there is a fair amount of assuming going on by high government officials and those that are practicing ‘evidence based medicine.’ The main assumption of course that this vaccine is perfectly safe. “Where is Novartis and others receiving their information from,” one may ask? The package insert for Novartis clearly states,

“Safety data were collected in a total of 2768 adult and geriatric subjects (18 years of age and older) who have received FLUVIRIN in 29 clinical studies since 1982.” (pg 6)

“In 9 clinical studies since 1997, among 1261 recipients of FLUVIRIN, 745 (59%) were women; 1211 (96%) were White, 23 (2%) Asian, 15 (1%) Black and 12 (1%) other; 370 (29%) of subjects were elderly (≥65 years of age). All studies have been conducted in the UK, apart from a study run in the US in 2005-2006 where FLUVIRIN was used as a comparator for an unlicensed vaccine.” (pg 6)

“In 1987 a clinical study was carried out in 38 ‘at risk’ children aged between 4 and 12 years (17 females and 21 males)…Three clinical studies were carried out between 1995 and 2004 in a total of 520 pediatric subjects (age range 6 – 47 months).” (pg 10)

Are they implying no testing has been completed for this new experimental H1N1 Swine Flu vaccine? I can see the logic of someone believing that the experimental H1N1 Swine Flu vaccine is safe predicated on the fact it is created with the same ‘technology’ as past shots. Moreover, when official bodies of government reiterate a sound byte, it sure is easier to believe.

If the aforementioned studies in the vaccine insert indicate vaccine safety, it doesn’t make much sense to have safety trials. Even more so, wouldn’t the clinical studies performed would be totally useless if, by example, different formulations were different? It appears what is being said and what is being done are entirely different matters altogether.

SWINE FLU VACCINE TRIAL CONTRADICTS ‘OFFICIAL STORY’

Looking at the CDC’s website for the ingredients of FLUVIRIN, we see it contains the following ingredients:

“Beta-Propiolactone , Egg Protein, Neomycin, Polymyxin B, Polyoxyethylene 9-10 Nonyl Phenol (Triton N-101, Octoxynol 9), Thimerosal (multidose containers), Thimerosal* (single-dose syringes)” (page 2)

Yet if we look at what is being tested in the trial we can abundantly see the two vaccines are not the same. Please look at page 2 of 13 of the experimental swine flu vaccine paperwork.

“MF59 is an adjuvant which is used in influenza vaccines licensed for adults and/or elderly in many countries worldwide, but it is not contained in any vaccines currently approved in the United States.”

If the MF59 adjuvant is approved for adults and elderly in different countries, but not approved in the United States, and at the same time we are having clinical trials on children now, how valid are those referenced studies in the FDA-approved-vaccine-inserts? That doesn’t appear to be evidence based to many in the scientific communities.

Nonoxynol-9 (which is a spermicide) mentioned on page 8 of the vaccine trial document is not mentioned as an ingredient in FLUVIRIN, according to the CDC’s website. Additionally, just because a vaccine has been manufactured by using the same process as the H1N1 vaccine insert implies, does not mean it has the same ingredients as past vaccines. Therefore, we cannot be presumptuous that all is well in the land of neurology or immunology.

Moreover, it appears that the Novartis Swine Flu vaccine insert is mostly a copied and pasted from the FLUVIRIN insert. Both inserts indicate that the vaccine is not for use for children under four years of age. Yet, Novartis is having a trial as I write this on three year old boys and girls. Even harder to grasp is the CDC’s recommendation that pregnant women and children 6-months of age are being shoved to the front of the line for being vaccinated.

The cruel irony on page 2 of the Novartis Swine Flu vaccine insert remarks,

“Safety and effectiveness of Influenza A (H1N1) 2009 Monovalent Vaccine have not been established in pregnant women, nursing mothers or children less than 4 years of age. (8.1, 8.3, 8.4)“

UNIVERSAL DECLARATIONS

I seem to recall not too long ago the FDA engaging in a witch hunt to prevent any alternative treatments for the H1N1 Swine Flu. In a press release, “FDA Warns Web Sites against Marketing Fraudulent H1N1 Flu Virus Claims” the FDA boldly declared,

“…the FDA warned consumers regarding products related to the 2009 H1N1 flu virus offered on the Internet. The products involved are those that are promoted and marketed to diagnose, mitigate, prevent, treat, or cure the 2009 H1N1 flu virus but are not approved, cleared, or authorized by the FDA. The agency advised operators of offending Web sites that they must take immediate action to ensure that they are not marketing products intended to diagnose, mitigate, prevent, treat, or cure the 2009 H1N1 flu virus that have not been cleared, approved, or authorized by the FDA.”

“The FDA will consider further civil or criminal enforcement action against those Web sites that fail to resolve the violations cited in warning letters. Actions could include seizure, injunction, and criminal prosecution.”

Let’s get this straight. The powers that be at the FDA asserts unequivocally that the experimental vaccines are safe and effective while some safety trials for the vaccines have not even been started. The formulations are clearly not the same from past flu vaccines although they are being treated as such. Additionally, testing is being conducted on children who are younger than the recommended ages in the vaccine inserts. Lastly, pregnant women and infants are FIRST in line for this vaccine. It almost all seems a bit criminal, doesn’t it?

When the FDA states that it will consider civil or criminal enforcement against blatantly falsified information, perhaps they can look no further than their own backyard.

FDA Warns Web Sites against Marketing Fraudulent H1N1 Flu Virus Claims
-------------------------------------------------------------​-------------------
VacTRUTH Editor’s Note:

1. A great resource for readers to understand how vaccines are made and information about them can be located at: [link to www.trackingvaccinations.com] (HIGHLY RECOMMENDED!!!)


2. The swine flu vaccine will have 25 mcg of thimerosal. A good read on the topic can be found here: [link to katysexposure.wordpress.com]

.Trackbacks / Pings
1.Ingredients Found in Spermicides, Cleaners, and Cosmetics along with Thimerosal, and Squalene Present in Experimental H1N1 Vaccine | VacTRUTH
2.FDA Approves Experimental H1N1 Swine Flu Vaccine Prior to Children … | H1N1INFLUENZAVIRUS.US
3.GlobalGulag.com » Ingredients Found in Spermicides, Cleaners, and Cosmetics along with Thimerosal, and Squalene Present in Experimental H1N1 Vaccine
4.We Are Change Colorado Springs » Blog Archive » FDA Approves Experimental H1N1 Swine Flu Vaccine Prior to Children Safety Trials Beginning
5. Ingredients Found in Spermicides, Cleaners, and Cosmetics along with Thimerosal, and Squalene Present in Experimental H1N1 Vaccine — Holy Hormones, Honey! .Sign Up for the M.A.S.S. Newsletter!

Email:
Phone:
First Name:
Last Name:
Country: United States none Afghanistan Albania Algeria American Andorra Angola Anguilla Antarctica Antigua Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia Botswana Bouvet Is Brazil British Ind Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Isl Central Afr Chad Chile China Christmas Is Cocos Colombia Comoros Congo Congo Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Rep East Timor Ecuador Egypt El Salvador Equatorial Eritrea Estonia Ethiopia Falkland Faroe Islands Fiji Finland France France French Gu French Po French So Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea Guyana Haiti Heard Holy See Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Korea Korea Kuwait Kyrgyzstan Lao Latvia Lebanon Lesotho Liberia Libyan Arab Liechtenstein Lithuania Luxembourg Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Martinique Mauritania Mauritius Mayotte Mexico Micronesia Moldova Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands NewCaledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Northern Norway Oman Pakistan Palau Panama Papua Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Rwanda Saint Kitts Saint LUCIA Saint Vin Samoa San Marino Sao Tome SaudiArabia Senegal Seychelles Sierra Le Singapore Slovakia Slovenia Solomon Somalia South Af South Ge Spain Sri Lanka St. Helena St. Pierre Sudan Suriname Svalbard Swaziland Sweden Switzerland Syrian Arab Taiwan Tajikistan Tanzania Thailand Togo Tokelau Tonga Trinidad Tunisia Turkey Turkmenistan Turks Tuvalu Uganda Ukraine United Arab United Kin United States United States Uruguay Uzbekistan Vanuatu Venezuela Viet Nam Virgin Islands Virgin Islands Wallis Western Sahara Yemen Yugoslavia Zambia Zimbabwe
State: Select a State Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming


.Leaders in the Vaccine Truth Movement
•Citizens
•Medical Professionals
•Organizations
.Resource Links
•198 Methods of Nonviolent Action
•Conflicts of Interest?
•Graphs on Disease (Health Sentinel)
•Learn All About Vaccines Here
•National Center for Health Statistics
•Pandemic Flu Fliers
•Public Readiness and Emergency Preparedness Act
•Statistical Graphs on Autism
•Stop Mandatory Vaccines Here!
•Vaccination News
•Vaccines and Health
.Categories
Select Category Featured Multi-Media Interviews News Animals & Vaccines Disease Avian Flu H1N1 HPV Faked Medical Data General Herd Immunity Newsletters Dr. Andrew Moulden Dr. Andrew Wakefield Dr. Mayer Eisenstein Dr. Rebecca Carley Dr. Rima E. Laibow Dr. Sherri Tenpenny Dr. Tim O’Shea Dr. True Ott Jeffry John Aufderheide Undue Influence Vaccine Development Vaccine Reactions Autism Vaccine Snafus Notable Quotables Vaccine History Timeline .Recent Articles
•Swine Flu Virus Created from Pig Vaccine?
•CONFIDENTIAL – Thimerosal VSD Study Phase I
•FDA Approves Experimental H1N1 Swine Flu Vaccine Prior to Children Safety Trials Beginning
•Flu Vaccines and the Risk of Cancer
•Chris Yankowski’s InTheoryTV interviews Jeffry John Aufderheide
•H1N1 Swine Flu Vaccine Test Patient Coughs Up Blood, Dismissed by Researchers
•Ingredients Found in Spermicides, Cleaners, and Cosmetics along with Thimerosal, and Squalene Present in Experimental H1N1 Vaccine
•Ghostwriting Is Called Rife in Medical Journals
•The Engineering of Pandemics
•A Lesson Not Learned in Vaccinology: The Man-Made Peanut Allergy Epidemic
•Offit’s Failure to Disclose Jeopardizes Swine Flu Vaccine Program
•Dr. Tim O’Shea September Newsletter on Vaccines and Nutrition
•Is the Killer the Parent or the Doctor? Vaccines and Shaken Baby Syndrome
.Queries
safety of h1n1 flu shot for pregnant h1n1 flu vaccine ingredients Sanofi-Pasteur of France h1n1 fda approved subjects Medimmune h1n1 subjects fda approval h1n1 vaccine ingredients swine flu vaccine csl limited h1n1 vaccine ingredients novartis h1n1 vaccine package insert h1n1 vaccine insert/medimmune h1n1 safety trials thimerosal h1n1 novartis nonoxynol-9 flu vaccine how are the h1n1 trials on children going? cdc h1n1 flu shot ingredients 2009 Monovalent Vaccine (CSL Limited) adjuvant safety of h1n1 flu vaccine package inserts H1N1 vaccine h1n1 flu vaccine safety recommended ages for h1n1 vac how safe is the h1n1 vaccine h1n1 flu vaccine ingredients cdc swine flu vaccine ingredients h1n1 vaccine insert swine flu ingredients safety of h1n1 flu shots novartis swine flu vaccine package insert experimental h1n1 the insert for the h1n1 vaccines swine vaccine on same day as flu H1N1 vaccine and safety h1n1 flu vaccines mf-59 Package insert and H1N1 vaccine h1n1 vaccine safety children h1n1 flu shot and autism ingredients in intranasal h1n1 vaccine FDA announced is was using only 4 companies to treat H1N1 h1n1 vaccine package insert swine flu vaccine insert H1N1 Flu vaccine been tested on pregnant women is it safe? h1 n1 nursing moms saftey and ingredients of new h1n1 vaccine h1n1 vaccine fda children h1n1 vaccine ingredients fda approved swine flu vaccine approved containing squalene h1n1 inserts ingredient package insert h1n1 vaccine evidence test FDA swine flu vaccine h1n1 vaccine ingredients cdc nonoxynol 9 and flu vaccines Oklahoma children to be tested with new H1N1 flu vaccine fuzzy seo..

.
Namaste

A small body of determined spirits fired by an unquenchable faith in their mission can alter the course of history
M. K. Gandhi





GLP